866-997-4948(US-Canada Toll Free)

Published on : Mar 10, 2015

Serum Institute of India is all set to launch 65,000 doses of NasoVac S in the market to contain the growing number of swine flu cases in the country. The dose that is administered via a nasal drop will help fight the spread of this disease in various parts of India. It was only a year ago that the company had to destroy about a million of doses as there weren’t any patients. However, the dangerous spread of this disease in January and February 2015 has led to a huge demand for this vaccine in the country. 

Dr. Rajeev Dhere, the Executive Director of the Serum Institute stated that by last year the vaccines had crossed their shelf life and the company had to restart the manufacturing. The company is now ready to launch the drug anytime. This vaccine is a promise to many patients suffering from swine flu and also a protection against influenza A and B. Since January 2015, several have succumbed to swine flu in Maharashtra and in many other states of India. The state surveillance officer reported that about 405 patients have been admitted to hospitals, while 42 out of these are on the ventilator. The hospitals in the state have screen about 2.46 lakh people for symptoms and another 25,850 have been prescribed the oseltamivir tablets. The state of Maharashtra has reported 2,589 swine flu cases so far. 

So far the doctors have obtained and distributed 3000 doses of injectable vaccine of Sanofi Pasteur. Out of these Pune got 800. However, the concern about volunteers ready for immunization still looms like a dark cloud without a silver lining.